Cargando…

3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells

Understanding the effects induced by carcinogens on primary colonic epithelial cells and how to counteract them might help to prevent colon cancer, which is one of the most frequent and aggressive cancers. In this study, we exposed primary human colonic epithelial cells (HCoEpC) to Benzo[a]pyrene (B...

Descripción completa

Detalles Bibliográficos
Autores principales: Santarelli, Roberta, Pompili, Chiara, Gilardini Montani, Maria Saveria, Evangelista, Lorenzo, Gonnella, Roberta, Cirone, Mara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948646/
https://www.ncbi.nlm.nih.gov/pubmed/35336037
http://dx.doi.org/10.3390/pharmaceutics14030663
_version_ 1784674703119482880
author Santarelli, Roberta
Pompili, Chiara
Gilardini Montani, Maria Saveria
Evangelista, Lorenzo
Gonnella, Roberta
Cirone, Mara
author_facet Santarelli, Roberta
Pompili, Chiara
Gilardini Montani, Maria Saveria
Evangelista, Lorenzo
Gonnella, Roberta
Cirone, Mara
author_sort Santarelli, Roberta
collection PubMed
description Understanding the effects induced by carcinogens on primary colonic epithelial cells and how to counteract them might help to prevent colon cancer, which is one of the most frequent and aggressive cancers. In this study, we exposed primary human colonic epithelial cells (HCoEpC) to Benzo[a]pyrene (B[a]P) and found that it led to an increased production of pro-inflammatory cytokines and activated ERK1/2 and mTOR. These pathways are known to be involved in inflammatory bowel disease (IBD), which represents a colon cancer risk factor. Moreover, B[a]P reduced autophagy and mitophagy, processes whose dysregulation has been clearly demonstrated to predispose to cancer either by in vitro or in vivo studies. Interestingly, all the effects induced by B[a]P could be counteracted by 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol, H), the most powerful anti-inflammatory and antioxidant compound contained in olive oil. This study sheds light on the mechanisms that could be involved in colon carcinogenesis induced by a chemical carcinogen and identifies a safe natural product that may help to prevent them.
format Online
Article
Text
id pubmed-8948646
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89486462022-03-26 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells Santarelli, Roberta Pompili, Chiara Gilardini Montani, Maria Saveria Evangelista, Lorenzo Gonnella, Roberta Cirone, Mara Pharmaceutics Article Understanding the effects induced by carcinogens on primary colonic epithelial cells and how to counteract them might help to prevent colon cancer, which is one of the most frequent and aggressive cancers. In this study, we exposed primary human colonic epithelial cells (HCoEpC) to Benzo[a]pyrene (B[a]P) and found that it led to an increased production of pro-inflammatory cytokines and activated ERK1/2 and mTOR. These pathways are known to be involved in inflammatory bowel disease (IBD), which represents a colon cancer risk factor. Moreover, B[a]P reduced autophagy and mitophagy, processes whose dysregulation has been clearly demonstrated to predispose to cancer either by in vitro or in vivo studies. Interestingly, all the effects induced by B[a]P could be counteracted by 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol, H), the most powerful anti-inflammatory and antioxidant compound contained in olive oil. This study sheds light on the mechanisms that could be involved in colon carcinogenesis induced by a chemical carcinogen and identifies a safe natural product that may help to prevent them. MDPI 2022-03-17 /pmc/articles/PMC8948646/ /pubmed/35336037 http://dx.doi.org/10.3390/pharmaceutics14030663 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Santarelli, Roberta
Pompili, Chiara
Gilardini Montani, Maria Saveria
Evangelista, Lorenzo
Gonnella, Roberta
Cirone, Mara
3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells
title 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells
title_full 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells
title_fullStr 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells
title_full_unstemmed 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells
title_short 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells
title_sort 3,4-dihydroxyphenylethanol (dpe or hydroxytyrosol) counteracts erk1/2 and mtor activation, pro-inflammatory cytokine release, autophagy and mitophagy reduction mediated by benzo[a]pyrene in primary human colonic epithelial cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948646/
https://www.ncbi.nlm.nih.gov/pubmed/35336037
http://dx.doi.org/10.3390/pharmaceutics14030663
work_keys_str_mv AT santarelliroberta 34dihydroxyphenylethanoldpeorhydroxytyrosolcounteractserk12andmtoractivationproinflammatorycytokinereleaseautophagyandmitophagyreductionmediatedbybenzoapyreneinprimaryhumancolonicepithelialcells
AT pompilichiara 34dihydroxyphenylethanoldpeorhydroxytyrosolcounteractserk12andmtoractivationproinflammatorycytokinereleaseautophagyandmitophagyreductionmediatedbybenzoapyreneinprimaryhumancolonicepithelialcells
AT gilardinimontanimariasaveria 34dihydroxyphenylethanoldpeorhydroxytyrosolcounteractserk12andmtoractivationproinflammatorycytokinereleaseautophagyandmitophagyreductionmediatedbybenzoapyreneinprimaryhumancolonicepithelialcells
AT evangelistalorenzo 34dihydroxyphenylethanoldpeorhydroxytyrosolcounteractserk12andmtoractivationproinflammatorycytokinereleaseautophagyandmitophagyreductionmediatedbybenzoapyreneinprimaryhumancolonicepithelialcells
AT gonnellaroberta 34dihydroxyphenylethanoldpeorhydroxytyrosolcounteractserk12andmtoractivationproinflammatorycytokinereleaseautophagyandmitophagyreductionmediatedbybenzoapyreneinprimaryhumancolonicepithelialcells
AT cironemara 34dihydroxyphenylethanoldpeorhydroxytyrosolcounteractserk12andmtoractivationproinflammatorycytokinereleaseautophagyandmitophagyreductionmediatedbybenzoapyreneinprimaryhumancolonicepithelialcells